Treatment with Lobeglitazone Attenuates Hepatic Steatosis in Diet-Induced Obese Mice
Nonalcoholic fatty liver disease (NAFLD) is strongly associated with insulin resistance. The peroxisome proliferator-activated receptor (PPAR) activators, thiazolidinediones, (TZDs), are insulin sensitizers used as a treatment for NAFLD. However, TZDs are a controversial treatment for NAFLD because...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2018-01-01
|
| coleção: | PPAR Research |
| Acesso em linha: | http://dx.doi.org/10.1155/2018/4292509 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|